메뉴 건너뛰기




Volumn 1, Issue 6, 2007, Pages 626-633

Plant sterols added to combination statin and colesevelam hydrochloride therapy failed to lower low-density lipoprotein cholesterol concentrations

Author keywords

Absorption; Colesevelam; Hydroxymethylglutaryl CoA reductase inhibitors; Hyperlipidemia; Phytosterols

Indexed keywords

APOLIPOPROTEIN B; ATORVASTATIN; C REACTIVE PROTEIN; CHOLESTEROL; COLESEVELAM; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MEVINOLIN; MINUTE MAID HEART WISE; PHYTOSTEROL; PLACEBO; SIMVASTATIN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

EID: 36848999398     PISSN: 19332874     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacl.2007.10.004     Document Type: Article
Times cited : (11)

References (28)
  • 1
    • 33846857559 scopus 로고    scopus 로고
    • Heart disease and stroke statistics-2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee
    • Rosamond W., Flegal K., Friday G., et al. Heart disease and stroke statistics-2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 115 (2007) e69-e171
    • (2007) Circulation , vol.115
    • Rosamond, W.1    Flegal, K.2    Friday, G.3
  • 2
    • 0032572086 scopus 로고    scopus 로고
    • Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study
    • Downs J.R., Clearfield M., Weis S., et al. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study. JAMA 279 (1998) 1615-1622
    • (1998) JAMA , vol.279 , pp. 1615-1622
    • Downs, J.R.1    Clearfield, M.2    Weis, S.3
  • 3
    • 0037031061 scopus 로고    scopus 로고
    • MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial
    • Heart Protection Study Collaborative G.
    • Heart Protection Study Collaborative G. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 360 (2002) 7-22
    • (2002) Lancet , vol.360 , pp. 7-22
  • 4
    • 0027987849 scopus 로고
    • Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)
    • Scandinavian Simvastation Survival Study Group
    • Scandinavian Simvastation Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 344 (1994) 1383-1389
    • (1994) Lancet , vol.344 , pp. 1383-1389
  • 5
    • 0342981862 scopus 로고    scopus 로고
    • The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators
    • Sacks F.M., Pfeffer M.A., Moye L.A., et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators. N Engl J Med 335 (1996) 1001-1009
    • (1996) N Engl J Med , vol.335 , pp. 1001-1009
    • Sacks, F.M.1    Pfeffer, M.A.2    Moye, L.A.3
  • 6
    • 0028883828 scopus 로고
    • Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group
    • Shepherd J., Cobbe S.M., Ford I., et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. N Engl J Med 333 (1995) 1301-1307
    • (1995) N Engl J Med , vol.333 , pp. 1301-1307
    • Shepherd, J.1    Cobbe, S.M.2    Ford, I.3
  • 7
    • 0032487931 scopus 로고    scopus 로고
    • Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels
    • The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group
    • The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. N Engl J Med 339 (1998) 1349-1357
    • (1998) N Engl J Med , vol.339 , pp. 1349-1357
  • 8
    • 0035897696 scopus 로고    scopus 로고
    • Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)
    • Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults
    • Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285 (2001) 2486-2497
    • (2001) JAMA , vol.285 , pp. 2486-2497
  • 9
    • 0034723758 scopus 로고    scopus 로고
    • The lipid treatment assessment project (L-TAP): a multicenter survey to evaluate the percentages of dyslipidemic patients receiving lipid-lowering therapy and achieving low-density lipoprotein cholesterol goals
    • Pearson T.A., Laurora I., Chu H., and Kafonek S. The lipid treatment assessment project (L-TAP): a multicenter survey to evaluate the percentages of dyslipidemic patients receiving lipid-lowering therapy and achieving low-density lipoprotein cholesterol goals. Arch Intern Med 160 (2000) 459-467
    • (2000) Arch Intern Med , vol.160 , pp. 459-467
    • Pearson, T.A.1    Laurora, I.2    Chu, H.3    Kafonek, S.4
  • 10
    • 3142729178 scopus 로고    scopus 로고
    • Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines
    • Grundy S.M., Cleeman J.I., Merz C.N.B., et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation 110 (2004) 227-239
    • (2004) Circulation , vol.110 , pp. 227-239
    • Grundy, S.M.1    Cleeman, J.I.2    Merz, C.N.B.3
  • 11
    • 0036805514 scopus 로고    scopus 로고
    • Additive effect of plant sterol-ester margarine and cerivastatin in lowering low-density lipoprotein cholesterol in primary hypercholesterolemia
    • Simons L.A. Additive effect of plant sterol-ester margarine and cerivastatin in lowering low-density lipoprotein cholesterol in primary hypercholesterolemia. Am J Cardiol 90 (2002) 737-740
    • (2002) Am J Cardiol , vol.90 , pp. 737-740
    • Simons, L.A.1
  • 12
    • 0034237228 scopus 로고    scopus 로고
    • Incremental reduction of serum total cholesterol and low-density lipoprotein cholesterol with the addition of plant stanol ester-containing spread to statin therapy
    • Blair S.N., Capuzzi D.M., et al. Incremental reduction of serum total cholesterol and low-density lipoprotein cholesterol with the addition of plant stanol ester-containing spread to statin therapy. Am J Cardiol 86 (2000) 46-52
    • (2000) Am J Cardiol , vol.86 , pp. 46-52
    • Blair, S.N.1    Capuzzi, D.M.2
  • 14
    • 2942514117 scopus 로고    scopus 로고
    • Plant sterol-fortified orange juice effectively lowers cholesterol levels in mildly hypercholesterolemic healthy individuals
    • Devaraj S., Jialal I., and Vega-Lopez S. Plant sterol-fortified orange juice effectively lowers cholesterol levels in mildly hypercholesterolemic healthy individuals. Arterioscler Thromb Vasc Biol 24 (2004) e25-e28
    • (2004) Arterioscler Thromb Vasc Biol , vol.24
    • Devaraj, S.1    Jialal, I.2    Vega-Lopez, S.3
  • 15
    • 0015348189 scopus 로고
    • Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge
    • Friedewald W.T., Levy R.I., and Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18 (1972) 499-502
    • (1972) Clin Chem , vol.18 , pp. 499-502
    • Friedewald, W.T.1    Levy, R.I.2    Fredrickson, D.S.3
  • 16
    • 0035313336 scopus 로고    scopus 로고
    • Efficacy and safety of combination simvastatin and colesevelam in patients with primary hypercholesterolemia
    • Knapp H.H., Schrott H., Ma P., et al. Efficacy and safety of combination simvastatin and colesevelam in patients with primary hypercholesterolemia. Am J Med 110 (2001) 352-360
    • (2001) Am J Med , vol.110 , pp. 352-360
    • Knapp, H.H.1    Schrott, H.2    Ma, P.3
  • 17
    • 0034994041 scopus 로고    scopus 로고
    • Low-dose combination therapy with colesevelam hydrochloride and lovastatin effectively decreases low-density lipoprotein cholesterol in patients with primary hypercholesterolemia
    • Davidson M.H., Toth P., Weiss S., et al. Low-dose combination therapy with colesevelam hydrochloride and lovastatin effectively decreases low-density lipoprotein cholesterol in patients with primary hypercholesterolemia. Clin Cardiol 24 (2001) 467-474
    • (2001) Clin Cardiol , vol.24 , pp. 467-474
    • Davidson, M.H.1    Toth, P.2    Weiss, S.3
  • 18
    • 0034802407 scopus 로고    scopus 로고
    • Coadministration of colesevelam hydrochloride with atorvastatin lowers LDL cholesterol additively
    • Hunninghake D., Insull Jr. W., Toth P., Davidson D., Donovan J.M., and Burke S.K. Coadministration of colesevelam hydrochloride with atorvastatin lowers LDL cholesterol additively. Atherosclerosis 158 (2001) 407-416
    • (2001) Atherosclerosis , vol.158 , pp. 407-416
    • Hunninghake, D.1    Insull Jr., W.2    Toth, P.3    Davidson, D.4    Donovan, J.M.5    Burke, S.K.6
  • 19
    • 33645735636 scopus 로고    scopus 로고
    • Effects of colesevelam hydrochloride on low-density lipoprotein cholesterol and high-sensitivity C-reactive protein when added to statins in patients with hypercholesterolemia
    • Bays H.E., Davidson M., Jones M.R., and Abby S.L. Effects of colesevelam hydrochloride on low-density lipoprotein cholesterol and high-sensitivity C-reactive protein when added to statins in patients with hypercholesterolemia. Am J Cardiol 97 (2006) 1198-1205
    • (2006) Am J Cardiol , vol.97 , pp. 1198-1205
    • Bays, H.E.1    Davidson, M.2    Jones, M.R.3    Abby, S.L.4
  • 20
    • 0033552130 scopus 로고    scopus 로고
    • Colesevelam hydrochloride (cholestagel): a new, potent bile acid sequestrant associated with a low incidence of gastrointestinal side effects
    • Davidson M.H., Dillon M.A., Gordon B., et al. Colesevelam hydrochloride (cholestagel): a new, potent bile acid sequestrant associated with a low incidence of gastrointestinal side effects. Arch Intern Med 159 (1999) 1893-1900
    • (1999) Arch Intern Med , vol.159 , pp. 1893-1900
    • Davidson, M.H.1    Dillon, M.A.2    Gordon, B.3
  • 21
    • 33747160207 scopus 로고    scopus 로고
    • Effects of colesevelam hydrochloride (WelChol) on biomarkers of inflammation in patients with mild hypercholesterolemia
    • Devaraj S., Autret B., and Jialal I. Effects of colesevelam hydrochloride (WelChol) on biomarkers of inflammation in patients with mild hypercholesterolemia. Am J Cardiol 98 (2006) 641-643
    • (2006) Am J Cardiol , vol.98 , pp. 641-643
    • Devaraj, S.1    Autret, B.2    Jialal, I.3
  • 22
    • 0036464008 scopus 로고    scopus 로고
    • LDL cholesterol lowering by bile acid malabsorption during inhibited synthesis and absorption of cholesterol in hypercholesterolemic coronary subjects
    • Gylling H., and Miettinen T.A. LDL cholesterol lowering by bile acid malabsorption during inhibited synthesis and absorption of cholesterol in hypercholesterolemic coronary subjects. Nutr Metab Cardiovasc Dis 12 (2002) 19-23
    • (2002) Nutr Metab Cardiovasc Dis , vol.12 , pp. 19-23
    • Gylling, H.1    Miettinen, T.A.2
  • 23
    • 0028830069 scopus 로고
    • Lack of efficacy of low-dose sitostanol therapy as an adjunct to a cholesterol-lowering diet in men with moderate hypercholesterolemia
    • Denke M.A. Lack of efficacy of low-dose sitostanol therapy as an adjunct to a cholesterol-lowering diet in men with moderate hypercholesterolemia. Am J Clin Nutr 61 (1995) 392-396
    • (1995) Am J Clin Nutr , vol.61 , pp. 392-396
    • Denke, M.A.1
  • 24
    • 36849043795 scopus 로고    scopus 로고
    • STAT!Ref Online Electronic Medical Library. 24:06:04 Bile Acid Sequestrants
    • McEvoy G.K. (Ed), American Society of Health-System Pharmacists, Inc, Bethesda, MD Accessed May 23, 2007
    • STAT!Ref Online Electronic Medical Library. 24:06:04 Bile Acid Sequestrants. In: McEvoy G.K. (Ed). AHFS Drug Information (2007), American Society of Health-System Pharmacists, Inc, Bethesda, MD. http://online.statref.com/document.aspx?fxid=1&docid=424 Accessed May 23, 2007
    • (2007) AHFS Drug Information
  • 25
    • 4344624966 scopus 로고    scopus 로고
    • Phytosterols and cholesterol metabolism
    • Ostlund Jr. R.E. Phytosterols and cholesterol metabolism. Curr Opin Lipidol 15 (2004) 37-41
    • (2004) Curr Opin Lipidol , vol.15 , pp. 37-41
    • Ostlund Jr., R.E.1
  • 26
    • 0042206849 scopus 로고    scopus 로고
    • Efficacy and safety of plant stanols and sterols in the management of blood cholesterol levels
    • Katan M.B., Grundy S.M., Jones P., et al. Efficacy and safety of plant stanols and sterols in the management of blood cholesterol levels. Mayo Clin Proc 78 (2003) 965-978
    • (2003) Mayo Clin Proc , vol.78 , pp. 965-978
    • Katan, M.B.1    Grundy, S.M.2    Jones, P.3
  • 27
    • 0035957037 scopus 로고    scopus 로고
    • AHA Science Advisory. Stanol/sterol ester-containing foods and blood cholesterol levels. A statement for healthcare professionals from the Nutrition Committee of the Council on Nutrition, Physical Activity, and Metabolism of the American Heart Association
    • Lichtenstein A.H., and Deckelbaum R.J. AHA Science Advisory. Stanol/sterol ester-containing foods and blood cholesterol levels. A statement for healthcare professionals from the Nutrition Committee of the Council on Nutrition, Physical Activity, and Metabolism of the American Heart Association. Circulation 103 (2001) 1177-1179
    • (2001) Circulation , vol.103 , pp. 1177-1179
    • Lichtenstein, A.H.1    Deckelbaum, R.J.2
  • 28


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.